Hims & Hers Files Q2 2024 10-Q
Ticker: HIMS · Form: 10-Q · Filed: 2024-08-05T00:00:00.000Z
Sentiment: neutral
Topics: 10-Q, quarterly-report, financials
Related Tickers: HIMS
TL;DR
HIMS Q2 24 10-Q filed. Financials are in.
AI Summary
Hims & Hers Health, Inc. filed its 10-Q for the period ending June 30, 2024. The company reported its financial results for the second quarter of 2024. Key financial data and operational details are presented in this filing, which follows the company's previous name change from Oaktree Acquisition Corp. on April 12, 2019.
Why It Matters
This filing provides investors with the latest financial performance and operational updates for Hims & Hers Health, Inc., crucial for understanding the company's current health and future prospects.
Risk Assessment
Risk Level: medium — The filing is a standard quarterly report, but the healthcare and direct-to-consumer sectors can be volatile.
Key Numbers
- 2024-06-30 — Reporting Period End (End of the second quarter of 2024)
- 2024-08-05 — Filing Date (Date the 10-Q was submitted to the SEC)
Key Players & Entities
- Hims & Hers Health, Inc. (company) — Filer
- Oaktree Acquisition Corp. (company) — Former company name
- 20240630 (date) — Reporting period end date
- 20240805 (date) — Filing date
- Melissa Baird (person) — Chief Operating Officer
- Oluyemi Okupe (person) — Chief Financial Officer
FAQ
What is the reporting period for this 10-Q filing?
The reporting period for this 10-Q filing is the quarter ended June 30, 2024.
What was Hims & Hers Health, Inc.'s former company name?
Hims & Hers Health, Inc.'s former company name was Oaktree Acquisition Corp.
When did the company change its name from Oaktree Acquisition Corp.?
The company changed its name from Oaktree Acquisition Corp. on April 12, 2019.
Who is the Chief Operating Officer of Hims & Hers Health, Inc.?
Melissa Baird is the Chief Operating Officer of Hims & Hers Health, Inc.
Who is the Chief Financial Officer of Hims & Hers Health, Inc.?
Oluyemi Okupe is the Chief Financial Officer of Hims & Hers Health, Inc.
From the Filing
0001773751-24-000248.txt : 20240805 0001773751-24-000248.hdr.sgml : 20240805 20240805161551 ACCESSION NUMBER: 0001773751-24-000248 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 88 CONFORMED PERIOD OF REPORT: 20240630 FILED AS OF DATE: 20240805 DATE AS OF CHANGE: 20240805 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Hims & Hers Health, Inc. CENTRAL INDEX KEY: 0001773751 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-38986 FILM NUMBER: 241174975 BUSINESS ADDRESS: STREET 1: 2269 CHESTNUT ST STREET 2: #523 CITY: SAN FRANCISCO STATE: CA ZIP: 94123 BUSINESS PHONE: 415-851-0195 MAIL ADDRESS: STREET 1: 2269 CHESTNUT ST STREET 2: #523 CITY: SAN FRANCISCO STATE: CA ZIP: 94123 FORMER COMPANY: FORMER CONFORMED NAME: Oaktree Acquisition Corp. DATE OF NAME CHANGE: 20190412 10-Q 1 hims-20240630.htm 10-Q hims-20240630 FALSE 2024 Q2 0001773751 12/31 39 39 P4Y 2.083 2.083 Melissa Baird Chief Operating Officer 3/28/2025 172 Oluyemi Okupe Chief Financial Officer 361 Termination Oluyemi Okupe Chief Financial Officer 8/28/2025 359 1050976 xbrli:shares iso4217:USD iso4217:USD xbrli:shares hims:reportingUnit xbrli:pure hims:commonStockClass utr:D 0001773751 2024-01-01 2024-06-30 0001773751 us-gaap:CommonClassAMember 2024-08-02 0001773751 hims:CommonClassVMember 2024-08-02 0001773751 2024-06-30 0001773751 2023-12-31 0001773751 us-gaap:CommonClassAMember 2024-06-30 0001773751 us-gaap:CommonClassAMember 2023-12-31 0001773751 hims:CommonClassVMember 2023-12-31 0001773751 hims:CommonClassVMember 2024-06-30 0001773751 2024-04-01 2024-06-30 0001773751 2023-04-01 2023-06-30 0001773751 2023-01-01 2023-06-30 0001773751 us-gaap:CommonStockMember 2023-12-31 0001773751 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001773751 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0001773751 us-gaap:RetainedEarningsMember 2023-12-31 0001773751 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001773751 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0001773751 2024-01-01 2024-03-31 0001773751 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-03-31 0001773751 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0001773751 us-gaap:CommonStockMember 2024-03-31 0001773751 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001773751 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-03-31 0001773751 us-gaap:RetainedEarningsMember 2024-03-31 0001773751 2024-03-31 0001773751 us-gaap:CommonStockMember 2024-04-01 2024-06-30 0001773751 us-gaap:AdditionalPaidInCapitalMember 2024-04-01 2024-06-30 0001773751 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-04-01 2024-06-30 0001773751 us-gaap:RetainedEarningsMember 2024-04-01 2024-06-30 0001773751 us-gaap:CommonStockMember 2024-06-30 0001773751 us-gaap:AdditionalPaidInCapitalMember 2024-06-30 0001773751 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-06-30 0001773751 us-gaap:RetainedEarningsMember 2024-06-30 0001773751 us-gaap:CommonStockMember 2022-12-31 0001773751 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001773751 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001773751 us-gaap:RetainedEarningsMember 2022-12-31 0001773751 2022-12-31 0001773751 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001773751 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001773751 2023-01-01 2023-03-31 0001773751 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-03-31 0001773751 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001773751 us-gaap:CommonStockMember 2023-03-31 0001773751 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001773751 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-03-31 0001773751 us-gaap:RetainedEarningsMember 2023-03-31 0001773751 2023-03-31 0001773751 us-g